These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

136 related items for PubMed ID: 38926329

  • 1. Silencing MFN2 Drives WNT/β-catenin Nucleation to Reduce Sorafenib Sensitivity in Hepatocellular Carcinoma Cells.
    Zeng CM, Shao B, Chen YP, Ding GS.
    Curr Med Sci; 2024 Aug; 44(4):789-798. PubMed ID: 38926329
    [Abstract] [Full Text] [Related]

  • 2. Britannin inhibits hepatocellular carcinoma development and metastasis through the GSK-3β/β-catenin signaling pathway.
    Lu Q, Zhu J, Teng L, Chen C, Bi L, Chen W.
    Phytomedicine; 2024 Dec; 135():156126. PubMed ID: 39427522
    [Abstract] [Full Text] [Related]

  • 3. Decreased lncRNA HNF4A-AS1 facilitates resistance to sorafenib-induced ferroptosis of hepatocellular carcinoma by reprogramming lipid metabolism.
    Zhao Y, Han S, Zeng Z, Zheng H, Li Y, Wang F, Huang Y, Zhao Y, Zhuo W, Lv G, Wang H, Zhao G, Zhao E, Hu Y, Hu P, Zhao G.
    Theranostics; 2024 Dec; 14(18):7088-7110. PubMed ID: 39629121
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Wnt/β-Catenin Pathway-Mediated PD-L1 Overexpression Facilitates the Resistance of Non-Small Cell Lung Cancer Cells to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors.
    Huang Z, Wang J, Xia Z, Lv Q, Ruan Z, Dai Y.
    Discov Med; 2024 Nov; 36(190):2300-2308. PubMed ID: 39600284
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. TEAD2 Promotes Hepatocellular Carcinoma Development and Sorafenib Resistance via TAK1 Transcriptional Activation.
    Zhang Y, Ren Y, Dong G, Jiao Q, Guo N, Gao P, Li Y, Wang Y, Zhao W.
    Mol Cancer Res; 2024 Dec 03; 22(12):1102-1116. PubMed ID: 39106149
    [Abstract] [Full Text] [Related]

  • 14. Distinct metabolic phenotype renders β-catenin mutant hepatocellular carcinoma susceptible to treatment-induced ischemia.
    Weinfurtner K, Crainic JA, Tischfield D, Ackerman D, Kurian M, Woodard A, Li W, Gatmaytan I, Ostrowski D, Soulen MC, Dagli M, Shamimi-Noori S, Mondschein J, Sudheendra D, William Stavropoulos S, Reddy S, Khaddash T, Furth EE, Siegelman ES, Hunt SJ, Nadolski GJ, Kaplan D, Gade TPF.
    medRxiv; 2024 Nov 19. PubMed ID: 39606409
    [Abstract] [Full Text] [Related]

  • 15. USP7 facilitates deubiquitination of LRRC42 in colorectal cancer to accelerate tumorigenesis and augment Wnt/β-catenin signaling.
    Li Y, Sun X, Huang Z.
    Biochim Biophys Acta Mol Cell Res; 2025 Jan 19; 1872(1):119859. PubMed ID: 39393471
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. MOTS-c relieves hepatocellular carcinoma resistance to TRAIL-induced apoptosis under hypoxic conditions by activating MEF2A.
    Shen H, Nie J, Wang X, Li G, Zhao L, Jin Y, Jin L.
    Exp Cell Res; 2025 Jan 01; 444(1):114354. PubMed ID: 39581216
    [Abstract] [Full Text] [Related]

  • 18. The calcium-sensing receptor suppresses epithelial-to-mesenchymal transition and stem cell- like phenotype in the colon.
    Aggarwal A, Prinz-Wohlgenannt M, Gröschel C, Tennakoon S, Meshcheryakova A, Chang W, Brown EM, Mechtcheriakova D, Kállay E.
    Mol Cancer; 2015 Mar 18; 14():61. PubMed ID: 25879211
    [Abstract] [Full Text] [Related]

  • 19. PIWIL genes in hepatocellular carcinoma: a multi-omics approach uncovering dysregulated expression and ceRNA networks in mice.
    Huang H, Lu R, Peng S, Huang S, Mo Y, Li G.
    BMC Genom Data; 2024 Nov 27; 25(1):101. PubMed ID: 39604866
    [Abstract] [Full Text] [Related]

  • 20. A multi-omic analysis reveals that Gamabufotalin exerts anti-hepatocellular carcinoma effects by regulating amino acid metabolism through targeting STAMBPL1.
    Zheng P, Xu D, Cai Y, Zhu L, Xiao Q, Peng W, Chen B.
    Phytomedicine; 2024 Dec 27; 135():156094. PubMed ID: 39348778
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.